Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Silverman, N. Connolly, L. Balfour-Lynn, S. Godfrey (1972)
Long-term Trial of Disodium Cromoglycate and Isoprenaline in Children with AsthmaBritish Medical Journal, 3
(1998)
Third International Pediatric ConsensusStatementon theManagementofChildhoodAsthma.Pediatr Pulmonol 1998: 25:1–17
K. Nishikawa (1988)
THE EFFECTS OF REGULAR INHALATION OF DISODIUM CROMOGLYCATE (DSCG) AND SALBUTAMOL IN SEVERE AND INTRACTABLE ASTHMA PATIENTSNihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology, 2
B. Laube, A. Edwards, R. Dalby, P. Creticos, P. Norman (1998)
The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma.The Journal of allergy and clinical immunology, 101 4 Pt 1
(1996)
Efficacyand limitationsof inhaledanti - allergic therapy in asthma
(2000)
Japanese guidelines for the treatment and management of childhood asthma
(1998)
Third International Pediatric Consen - susStatementon theManagementofChildhoodAsthma
J. Warner, C. Naspitz, G. Cropp (1998)
Third International Pediatric Consensus statement on the management of childhood asthmaPediatric Pulmonology, 25
S. Kitamura, Y. Ishihara, F. Takaku (1984)
Effect of disodium cromoglycate on the action of bronchoactive agents in guinea-pig tracheal strips.Arzneimittel-Forschung, 34 9
(1969)
Disodiumcromoglycate in the control of asthma
G. Shapiro, C. Furukawa, W. Pierson, M. Sharpe, R. Menendez, C. Bierman (1988)
Double-blind evaluation of nebulized cromolyn, terbutaline, and the combination for childhood asthma.The Journal of allergy and clinical immunology, 81 2
M. MILNE, M. UTTING, M. BRESLIN, M. BATTEN, Physician Bignall, P. F.R.C.P., P. F.R.C.P., P. F.R.C.P., M. SCADDING, Professor TURNER-WARWICK, B.SC TALL, M. FOX (1972)
Long-term Study of Disodium Cromoglycate in Treatment of Severe Extrinsic or Intrinsic Bronchial Asthma in AdultsBritish Medical Journal, 4
Bernard Berman, Meryl Fenton, Leonard Girsh, Zack Haddad, William Sellars, Edward Strem, Hugh Thompson, Lester Wall (1975)
Cromolyn sodium in the treatment of children with severe, perennial asthma.Pediatrics, 55 5
(1975)
Cromolyn sodium in the treatmentofchildrenwithsevere,perennialasthma.Pediatrics
I. Bernstein, S. Siegel, M. Brandon, E. Brown, R. Evans, A. Feinberg, S. Friedlaender, R. Krumholz, R. Hadley, N. Handelman, D. Thurston, M. Yamate (1972)
A controlled study of cromolyn sodium sponsored by the Drug Committee of the American Academy of Allergy.The Journal of allergy and clinical immunology, 50 4
E. Iwasaki, M. Yamaura, M. Baba (1993)
[Assessment of the amount of drug deposited in the lungs of asthmatic children using disodium cromoglycate as the marker].Arerugi = [Allergy], 42 8
G. Leyton, H. Leyton (1937)
REGIONAL DISTRIBUTION OF CANCER IN THE OXFORD AREABritish Medical Journal, 2
(1975)
Cromolyn sodium in the treatmentofchildrenwithsevere , perennialasthma
M. Kennedy (1969)
Disodium cromoglycate in the control of asthma. A double-blind trial.British journal of diseases of the chest, 63 2
Kelly West (1964)
Emigration of DoctorsBritish Medical Journal, 1
(1972)
Acontrolledstudyof cromolyn sodium by the Drug Committee of the American Academy of Allergy
The aim of this multi‐centre prospective study was to evaluate the efficacy, tolerability, and safety of the combination of sodium cromoglycate (SCG) and salbutamol (administered as a nebulized solution), compared to SCG alone and salbutamol alone, in the management of severe, intractable asthma in childhood. The study was an open, randomized, cross‐over trial of 12 weeks' duration in children with moderate‐to‐severe intractable asthma. All treatments were administered twice daily by powered nebulizer. The primary outcome measure was the change in asthma severity, as measured by the mean asthma score during the last 2 weeks of a baseline period and the last 2 weeks of each treatment. Secondary outcome measure was the patient's opinion of the effectiveness of treatment. The change in asthma scores from baseline values were significantly greater with the combination treatment compared to each component administered separately. The mean difference in asthma score between the combination and salbutamol was: −7.5; 95% CI, −11.70 to −3.29 (p < 0.0001). The mean difference between the combination and SCG was: −8.53; 95% CI, −14.03 to −3.25 (p < 0.0001). Patients were also significantly in favor of combination treatment (p < 0.001 vs. salbutamol; p < 0.01 vs. SCG). Two patients reported adverse effects. We concluded that regular twice‐daily inhalation of a combination of SCG and salbutamol gave better control of symptoms than previous treatments in patients with severe, intractable asthma. Few adverse effects with this therapy suggest that it is extremely useful, safe, and effective.
Pediatric Allergy and Immunology – Wiley
Published: Jun 1, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.